BioMed Research International
Volume 2015 (2015), Article ID 414681, 12 pages
http://dx.doi.org/10.1155/2015/414681

Research Article

Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination of β-Lactam Resistance Genes among the Enterobacteriaceae

Marcin Adamczuk,¹ Piotr Zaleski,² Lukasz Dziewit,¹ Renata Wolinowska,³ Marta Nieckarz,¹ Pawel Wawrzyniak,1,2 Piotr Kieryl,² Andrzej Plucienniczak,² and Dariusz Bartosik¹

¹Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland
²Institute of Biotechnology and Antibiotics, Staroscinska 5, 02-516 Warsaw, Poland
³Department of Pharmaceutical Microbiology, Medical University of Warsaw, Oczki 3, 02-007 Warsaw, Poland

Received 23 December 2014; Accepted 22 June 2015

Academic Editor: Jorge F. Quarleri

Copyright © 2015 Marcin Adamczuk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Antibiotic resistance determinants are frequently associated with plasmids and other mobile genetic elements, which simplifies their horizontal transmission. Several groups of plasmids (including replicons of the IncL/M incompatibility group) were found to play an important role in the dissemination of resistance genes encoding β-lactamases. The IncL/M plasmids are large, broad host range, and self-transmissible replicons. We have identified and characterized two novel members of this group: pARM26 (isolated from bacteria inhabiting activated sludge from a wastewater treatment plant) and pIGT15 (originating from a clinical strain of Escherichia coli). This instigated a detailed comparative analysis of all available sequences of IncL/M plasmids encoding β-lactamases. The core genome of these plasmids is comprised of 20 genes with conserved synteny. Phylogenetic analyses of these core genes allowed clustering of the plasmids into four separate groups, which reflect their antibiotic resistance profiles. Examination of the biogeography of the IncL/M plasmids revealed that they are most frequently found in bacteria of the family Enterobacteriaceae originating from the Mediterranean region and Western Europe and that they are able to persist in various ecological niches even in the absence of direct antibiotic selection pressure.

1. Introduction

The discovery of antibiotics initiated a new era in medicine. However, in recent years, the rapidly growing antibiotic resistance of pathogenic bacterial strains has greatly hindered the fight against infectious diseases. This problem is particularly serious in relation to the use of β-lactam antibiotics due to the profusion and diversity of β-lactamases. The production of these enzymes by Gram-negative bacteria is the most important factor undermining the efficacy of treatment using this group of antibiotics [1].

Two major schemes are used to classify β-lactamases: molecular discrimination (proposed by Ambler) based on amino acid sequences and functional discrimination (proposed by Bush-Jacoby-Medeiros) dividing enzymes according to their substrate and inhibitor specificities [2]. The Ambler classification is more commonly used, with each β-lactamase class grouping proteins according to discernible features such as molecular weight or conserved amino acid motifs [3].

Ambler classes A, C, and D β-lactamases contain a serine residue in their active site, whereas class B includes metalloenzymes (MBLs: metallo-β-lactamases) that require zinc ions for substrate hydrolysis. Attempts have been made to assign specific substrates to β-lactamases of particular classes (e.g., class A as penicillinases), but this division has proven to be inaccurate as novel enzymes with modified activity profiles are discovered following the introduction of newly developed drugs into clinical practice. For example, a single amino acid alteration in the narrow-spectrum β-lactamase SHV-1 may lead to the emergence of enzymes that can hydrolyze extended-spectrum cephalosporins or even carbapenems [4].

The dissemination of β-lactamase genes and other antibiotic resistance determinants is a consequence of inter- and intraspecies DNA exchange, occurring mainly due to the transfer of bacterial plasmids. Plasmids are extrachromosomal DNA molecules capable of autonomous replication, which are the major players in horizontal gene transfer and are responsible for shaping bacterial resistomes. A harmless environmental strain may be transformed into a pathogen by the acquisition of a multiresistance plasmid [5].

Plasmids promote the horizontal transfer of antibiotic resistance genes among bacteria belonging to various species or genera. The spread of these genes depends on the host range and conjugative properties of plasmids. Thus, conjugative, broad host range replicons have the greatest impact on overall antibiotic resistance transmission [6, 7].

Amongst broad host range conjugative plasmids, special attention has been paid to IncL/M replicons, one of the six major resistance plasmid groups identified in clinically relevant Enterobacteriaceae [8, 9]. Plasmids representing this incompatibility group have been identified as carriers of various β-lactam resistance genes encoding extended-spectrum β-lactamases (ESBL), classes A, B, and D carbapenemases, and AmpC β-lactamases [10–21]. Plasmid pEL60 of Erwinia amylovora was recognized as an archetype for the IncL/M group. It lacks mobile elements and drug resistance genes, typical for other multiresistant IncL/M plasmids [22]. However, a detailed genomic analysis revealed the presence of backbone genes typical for all IncL/M replicons, including replication and stabilization modules, a conjugative transfer system and a mucAB-like mutagenic DNA repair system, which is closely related to the rulAB operon conferring tolerance to UV radiation [22].

This study comprises an analysis of the complete nucleotide sequences of two SHV-5 β-lactamase-encoding plasmids (pARM26 and pIGT15) isolated from environmental and clinical samples, plus a detailed meta-analysis of available sequence data describing IncL/M replicons carrying β-lactamase genes.

2. Materials and Methods

2.1. Bacterial Strains and Culture Conditions

Escherichia coli strains DH5α [23] and CZD1527 [24] were grown in lysogeny broth (LB) medium [25] at 30°C or 37°C. Plates of solidified LB medium were prepared by the addition of 1.5% agar. Where necessary, the medium was supplemented with ampicillin (100 μg/mL) and/or tetracycline (20 μg/mL).

2.2. Isolation of Plasmids

Plasmid pARM26 was isolated exogenously in 2011. A flask containing 19 mL of LB medium supplemented with ampicillin (100 μg/mL) was inoculated with 1 mL of return activated sludge from the “Czajka” wastewater treatment plant (Warsaw, Poland) and incubated overnight at 30°C with aeration. The bacterial growth was pelleted by centrifugation and plasmid DNA isolated by alkaline lysis. E. coli DH5α was transformed with the purified DNA, selecting on LB agar plates supplemented with ampicillin (100 μg/mL) and tetracycline (20 μg/mL).

Plasmid pIGT15 was isolated in 2005 from the multiresistant and multireplicon E. coli strain CZD1527 obtained from a child hospitalized in The Children’s Memorial Health Institute in Warsaw (Poland) during the course of standard microbiological diagnostic testing.

2.3. DNA Sequencing

The complete nucleotide sequences of plasmids pARM26 and pIGT15 were determined using MiSeq sequencers (Illumina Inc.) in the DNA Sequencing and Oligonucleotide Synthesis Laboratory (oligo.pl) at the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (Warsaw, Poland) and StarSEQ (Mainz, Germany), respectively. After quality filtering, the sequence data were assembled into contigs and scaffolds using Newbler De Novo Assembler v3.0 (Roche). Gaps were closed by the PCR amplification of DNA fragments, followed by Sanger sequencing with an ABI3730xl Genetic Analyzer (Life Technologies) using BigDye Terminator Mix v. 3.1 chemistry (Life Technologies).

2.4. DNA Manipulations and the Transformation of Bacterial Cells with Plasmids

The isolation of plasmids and common DNA manipulation methods were carried out as described previously [25]. PCR was performed in a Mastercycler (Eppendorf) using Taq DNA polymerase (Qiagen; with the supplied buffer), dNTP mixture, and appropriate primer pairs. Transformation of E. coli strains was performed according to the method of Kushner [28].

2.5. Bioinformatics

The plasmid nucleotide sequences were analyzed using Clone Manager (Sci-Ed8) and Artemis [29]. Similarity searches were performed using the BLAST programs [30]. Identified insertion sequences were compared with the ISfinder database [31]. For comparative analyses of plasmid sequences, the Easyfig program was used [32]. Phylogenetic analysis of the IncL/M plasmids was performed using the EDGAR tool [33]. To construct the phylogenetic tree, 20 core genes from the 20 IncL/M plasmid genomes were compared. Multiple alignments were created using MUSCLE software [34] and the highly variable regions of these alignments were removed using Gblocks [35]. The remaining sections of the alignments were concatenated into one multiple alignment and used in the construction of a phylogenetic tree with PHYLIP software [36]. The tree was visualized using TreeView version 1.6.6. [37]. Singletons and the core genes, initially defined using the EDGAR tool, were manually verified with BLASTn.

2.6. Nucleotide Sequence Accession Numbers

The sequences of plasmids pARM26 and pIGT15 determined in this study have been deposited in GenBank (NCBI) with the accession numbers KP294350 and KP294351, respectively.

3. Results and Discussion

3.1. The Structure of Plasmids pARM26 and pIGT15

Two novel antibiotic resistance plasmids belonging to the IncL/M incompatibility group were isolated: pARM26 from bacteria inhabiting activated sludge and pIGT15 from a clinical E. coli isolate. DNA sequencing demonstrated that both pARM26 (86,948 bp) and pIGT15 (74,839 bp) are circular plasmids with mean GC contents of 54.4% and 54.7%, respectively. In silico sequence analyses revealed that the plasmids carry 107 (pARM26) and 88 (pIGT15) putative genes. A summary of these genes, including their position, transcriptional orientation, the size of the encoded proteins, and their closest known homologs, is presented in Table S1 (Supplementary Materials, available online at http://dx.doi.org/10.1155/2015/414681).

Comparative analyses of the plasmid genomes revealed high levels of synteny and sequence identity. Homologs of all the pIGT15 genes are also present in the pARM26 genome and the aligned nucleotide sequences show 99% identity. Plasmid pARM26 is approximately 12 kb larger than pIGT15 because it possesses two additional DNA regions named region I and region II (Figure 1). Region I (nucleotide position 18,704–20,614) contains genes encoding (i) a conserved membrane protein (pIGT15 carries a truncated homologous gene encoding only the N-terminal part of this protein), (ii) a putative L-fuculose-phosphate aldolase (EC 4.1.2.17; which can also function as a D-ribulose-phosphate aldolase) involved in the utilization of L-fucose and D-arabinose [38], and (iii) a hydroxypyruvate isomerase (EC 5.3.1.22, which catalyzes the reversible isomerization of hydroxypyruvate and tartronate semialdehyde [39]). The region II (nucleotide position 53,618–63,898) carries 17 genes encoding (i) a DNA repair protein RadC, (ii) a HTH_XRE transcriptional regulator, (iii) gene expression modulator RmoA, (iv) antirestriction protein KlcA, (v) a mobilization protein C, and (vi) 12 hypothetical proteins of unknown function.

Figure 1: Linear map showing the genetic structure of circular plasmids pACM1, pARM26, and pIGT15. Arrows indicate the direction of gene transcription. The gray-shaded area connects DNA regions of different plasmids with at least 99% nucleotide sequence identity. Yellow frames indicate DNA regions (I and II) of pARM26 not present within pIGT15. REP: replication system; TRA: conjugal transfer system; PAR: partitioning system; InA and InB: class 1 integrons.

Comparison with the GenBank database revealed that pARM26 and pIGT15 are most closely related to plasmid pACM1 of Klebsiella oxytoca [10]. As shown in Figure 1, the three plasmids share gene synteny and show high levels of sequence conservation. Plasmid pACM1, the largest of the replicons, has an additional unique DNA region containing a class I integron carrying two antibiotic resistance gene cassettes (Figure 1). Each of the plasmids also contains several transposable elements (TEs), including (i) the insertion sequences IS26 (2 copies; some in different genomic locations) and IS6100 (1 copy), both classified within the IS6 family [31] and (ii) a large Tn1721-like noncomposite Tn3 family transposon (of 28,815 bp in pARM26, 26,985 bp in pIGT15, and 31,842 bp in pACM1), which is absent in other members of the IncL/M group. These three closely related plasmids are self-transmissible replicons conferring resistance to multiple antibiotics, including aminoglycosides (aacA4, aacC1, and aadA1), trimethoprim (dfrA1, only in pACM1), sulfonamides (sul1), and tetracycline (tetA). They also encode an extended-spectrum β-lactamase (ESBL) belonging to the SHV family, SHV-5 (Figure 1). Interestingly, all of the resistance determinants are embedded within the aforementioned Tn3 family transposon (Figure 1).

It is important to mention that the bacterial host strains carrying these plasmids originated from different environments (i.e., nosocomial and nonnosocomial) and were isolated at different times. The plasmid pACM1 was isolated in 1993 from a cephalosporin-resistant K. oxytoca strain from the USA [40], pIGT15 in 2005 from a Polish clinical strain of E. coli, and pARM26 in 2011 from bacteria inhabiting a wastewater treatment plant, also in Poland. Comparative genomic analyses of other IncL/M replicons may shed light on the phylogeny and evolution of this group of antibiotic resistance plasmids, which play an important role in the dissemination of β-lactamase genes among members of the family Enterobacteriaceae.

3.2. Diversity and Comparative Genomics of the IncL/M Plasmids

To our knowledge, until now (December 2014), only eighteen complete nucleotide sequences of IncL/M plasmids have been deposited in public databases (Table 1). With the addition of the two replicons described in this study (pARM26 and pIGT15) the sequences of 20 plasmids from this group were available for comparative genomic analyses.

Table 1: IncL/M plasmid sequences deposited in the GenBank database.

Plasmid name
Host strain
Strain origin
Size
(bp)
%
GC
Reference/GenBank accession number

pACM1
Klebsiella oxytoca
New York, USA; hospital patient
89,977
54.4
[10]/NC_024997

pARM26
unknown bacterium
Warsaw, Poland; wastewater treatment plant
86,948
54.4
this work/KP294350

pCTX-M3
Citrobacter freundii 2526
Warsaw, Poland; hospital patient
89,468
51.0
[11]/NC_004464

pCTX-M360
Klebsiella pneumoniae 0773
Guangzhou, China; hospital patient
68,018
51.4
[12]/NC_011641

pE71T
Klebsiella pneumoniae E71T
Ireland; hospital patient
63,578
51.2
[13]/NC_023027

pEl1573
Enterobacter cloacae El1573
Sydney, Australia; hospital patient
87,731
52.8
[14]/NC_019368

pEL60
Erwinia amylovora LebB66
Lebanon; fruits
60,145
51.5
[22]/NC_005246

pENT-d0d
Enterobacter cloacae ECNIH5
Bethesda, USA; hospital sink drain
77,575
50.7
[26]/CP009857

pENT-e56
Enterobacter cloacae ECNIH4
Bethesda, USA; hospital sink drain
77,248
51.5
[26]/CP009852

pFOX-7a
Klebsiella pneumoniae 45A03
Siena, Italy; hospital patient
90,439
53.4
[15]/NC_025134

pIGT15
Escherichia coli CZD1527
Warsaw, Poland; hospital patient
74,839
54.7
this work/KP294351

pJEG011
Klebsiella pneumoniae Kp002
Sydney, Australia; hospital patient
71,446
50.6
[16]/NC_021078

pKOI-34
Klebsiella oxytoca MS5279
Japan; hospital patient
87,343
53.3
[27]/AB715422

pKPN-068
Klebsiella pneumoniae KPNIH27
USA; hospital patient
80,411
51.3
—/CP007733

pKPoxa-48N1
Klebsiella pneumoniae KP1a
Nancy, France; hospital patient
62,592
51.1
[17]/NC_021488

pNDM-HK
Escherichia coli HK-01
Hong Kong, China; hospital patient
88,803
51.5
[18]/NC_019063

pNDM-OM
Klebsiella pneumoniae 601
Oman; hospital patient
87,185
51.5
[19]/NC_019889

pNE1280
Enterobacter cloacae 1623
Omaha, USA; hospital patient
66,531
52.3
[20]/NC_019346

pOXA-48a
Klebsiella pneumoniae Kp11978
Turkey; hospital patient
61,881
51.1
[21]/NC_019154

R830b
Serratia marcescens
USA
81,793
53.2
—/NC_019344

Comparative analyses revealed that the pan-genome of the IncL/M plasmids consists of 248 genes. This is a relatively small number considering the fact that each of these large plasmids (of 60–90 kb in size; Table 1) carries about 100 genes. This finding indicates that the IncL/M plasmids are highly conserved, sharing the majority of their genes. It is also in accordance with the small number of unique genes (56) identified in the plasmid genomes. Only half of the analyzed IncL/M plasmids contain singletons (Table 2) and their number ranges from 0 to 15 per replicon. The highest number of singleton genes was found in plasmid R830b of Serratia marcescens, which does not carry any AR determinants. Several of these genes may play an important role in adaptation of the host strain to changing environmental conditions. Some appear to confer resistance to toxic heavy metals (mercury, cobalt, zinc, and cadmium), while others are probably engaged in formaldehyde detoxification (Table 2). Heavy metal resistance genes (an arsenic resistance gene cluster) were also identified in pKOI-34, another member of the IncL/M group (Table 2). The pool of singletons also includes 11 (19.6%) antibiotic resistance genes (aadA2, , , , , , dfrA1, dfrA12, mphA, strA, and strB), frequently associated with transposable elements (Table 2). This finding is in agreement with previous observations suggesting that the majority of AR genes of the IncL/M plasmids have been acquired within TEs (or mobile integron gene cassettes) inserted at “hotspot” sites in the highly conserved plasmid backbone [10].

Table 2: Unique genes identified within IncL/M plasmids.

Plasmid name
Number of singletons
Singleton gene/locus tag [possible function]

pACM1
1
dfrA1/D733_p1025 [dihydrofolate reductase]

pARM26
0
—

pCTX-M3
3
dfrA12/pCTX-M3_084 [dihydrofolate reductase]; orfF/pCTX-M3_085 [integron gene cassette, hypothetical protein]; aadA2/pCTX-M3_086 [streptomycin 3′-adenyltransferase]

pCTX-M360
0
—

pE71T
0
—

pEl1573
5
mphA/D727_p1024 [macrolide phosphorylase]; mrx/D727_p1026 [protein of unknown function, required for MphA expression]; mphR(A)/D727_p1027 [transcriptional regulator for macrolide phosphorylase gene mph(A)]; catB3/D727_p1035 [chloramphenicol acetyltransferase]; bla IMP-4/D727_p1038 [IMP-4 metallo--lactamase]

pEL60
2
orf8/pEL60p08 [hypothetical protein]; kfrA/pEL60p09 [plasmid maintenance protein KfrA]

pENT-d0d
0
—

pENT-e56
0
—

pFOX-7a
9
blaFOX-7/D647_p51042 [FOX-7 -lactamase]; mdrL/D647_p51043 [major facilitator transporter]; lysR/D647_p51044 [LysR family transcriptional regulator]; tnpA/D647_p51045 [transposase of IS1634-family insertion sequence]; tnpA/D647_p51046 [transposase of ISApu1 (IS4 family/ISH8 group)]; D647_p51047 [hypothetical protein]; tnpA/D647_p51048 [transposase of ISApu2 (IS4 family/ISH8 group)]; istA/D647_p51052 [IstA protein of IS1326 (IS21 family)]; istB/D647_p51053 [IstB protein of IS1326 (IS21 family)]

pIGT15
0
—

pJEG011
5
strA/D647_p23045 [streptomycin phosphotransferase A]; strB/D647_p23040 [streptomycin phosphotransferase B]; aphA6/D647_p23043 [aminoglycoside 3′-phosphotransferase]; tnpA/D647_p23042 [transposase of IS1-family insertion sequence]; bla CTX-M-14/D647_p23049 [extended-spectrum -lactamase]

pKOI-34
7
arsR [arsenical resistance operon repressor]; arsD [arsenical resistance operon transacting repressor]; arsA [arsenical pump-driving ATPase]; arsB [arsenic efflux pump protein]; arsC [arsenate reductase]; ycgA [arsenical pump-driving ATPase]; [IMP-34 metallo--lactamase]

pKPN-068
0
—

pKPoxa-48N1
0
—

pNDM-HK
1
insL/D616_p59011 [transposase of IS4 family/IS231 group insertion sequence]

pNDM-OM
0
—

pNE1280
8
istB/KPC4_0043 [IstB protein of IS21-family insertion sequence]; bla KPC-4/KPC4_0045 [β-lactamase]; tnpA/KPC4_0047 [transposase]; KPC4_0049 [hypothetical protein]; KPC4_0051 [hypothetical protein]; KPC4_0053 [hypothetical protein]; rom/KPC4_0055 [Rop family protein]; exc1/KPC4_0057 [exclusion protein 1]

pOXA-48a
0
—

R830b
15
tniQ/D739_p1005 [transposase helper protein TniQ]; D739_p1006 [resolvase/integrase]; D739_p1010 [organomercurial lyase]; D739_p1020 [putative reverse transcriptase]; D739_p1024 [hypothetical protein]; D739_p1025 [Il-IS_2, transposase]; D739_p1026 [lipoprotein signal peptidase]; D739_p1027 [cobalt-zinc-cadmium resistance protein CzcD]; D739_p1028 [Cd(II)/Pb(II)-responsive transcriptional regulator]; D739_p1029 [hypothetical protein]; D739_p1107 [resolvase]; D739_p1108 [S-formylglutathione hydrolase]; D739_p1109 [glyoxalase]; D739_p1110 [S-(hydroxymethyl)glutathione dehydrogenase]; D739_p1111 [uncharacterized protein YaiN in formaldehyde detoxification operon]

The core genome of the IncL/M plasmids consists of 20 genes, conserved in all the analyzed replicons. Functional classification of these genes revealed that they encode proteins involved in plasmid replication (repA, repC), stable plasmid maintenance (resD, parA), conjugal transfer (trbA, trbB, trbC, nikA, mobA, traH, traI, traJ, traM, traN, traO, traQ, traU, traW, and traY), and UV resistance (mucA). In an effort to understand the evolution of these plasmids, a phylogenetic analysis was performed based on the amino acid sequences of the proteins encoded by the core genes (Figure 2). Within the constructed phylogenetic tree, four main clusters are evident, grouping closely related replicons.

Figure 2: Comparative analyses of IncL/M plasmids. (a) Phylogenetic tree based on the 20 core genes of the IncL/M plasmids. (b) Comparative genomic analysis of the IncL/M plasmids (sequence annotations of several plasmids have been manually corrected; the distinguished genes are shown by arrows on the linear maps: red: bla genes; yellow: other AR genes). The gray-shaded areas connect DNA regions of different plasmids with at least 68% nucleotide sequence identity. (c–k) Comparison of the antibiotic resistance gene contents of the IncL/M plasmids: (c) β-lactam resistance genes; (d) aminoglycoside resistance genes; (e) macrolide resistance genes; (f) quinolone resistance genes; (g) trimethoprim resistance genes; (h) sulfonamide resistance genes; (i) bleomycin resistance genes; (j) chloramphenicol resistance genes; (k) tetracycline resistance genes.

The first cluster (cluster I) is comprised of the plasmids pARM26 and pIGT15, identified in this work, and also the closely related pACM1. All three are multiresistance replicons carrying 7 (or 8 in the case of pACM1 [10]) AR genes, including a tetA gene conferring resistance to tetracycline, which is not present in other IncL/M plasmids (Figure 2). The second cluster (cluster II) contains two multiresistance replicons (pFOX-7a, pNE1280) [15, 20] and plasmid pEL60 of the plant pathogen E. amylovora, which does not contain any AR genes [22] (Figure 2). The third and largest cluster (cluster III) is divided into two subclusters. The IIIA branch groups closely related plasmids pKPN-068, pENT-e56, and pENT-d0d, carrying five common, identical AR genes (, , aadB, qnrB19, and cat) [26], as well as the R830b replicon (containing no AR genes), which forms an outgroup within this subcluster (Figure 2). The IIIB branch gathers four similar plasmids (pOXA-48a, pJEG011, pKPoxa-48N1, and pE71T) with an embedded gene [13, 16, 17, 21]. Interestingly, within this subcluster there is only one multiresistance plasmid, pJEG011 [16] (Figure 2). The fourth cluster (cluster IV) is also divided into two smaller subclusters: IVA, consisting of two plasmids, pNDM-HK and pNDM-OM, with a high level of genetic synteny [18, 19], and IVB, grouping closely related plasmids pCTX-M3, pCTX-M360, and pEl1573 [11, 12, 14] (Figure 2).

The results of this phylogenetic analysis confirmed previous assumptions that there were probably several lineages of the IncL/M plasmids before they began acquiring diverse exogenous segments of DNA [10]. A more detailed comparative analysis showed that the insertions occurred within several “hotspots,” which are usually located between conserved core genes in the plasmid backbone. Insertions at other locations were observed in only a few cases, for example, in the plasmids pOXA-48a, pJEG011, pE71T, and pKPoxa-48N1 (all grouped in the subcluster IIIB), in which the acquired DNA interrupted the tir gene encoding a transfer inhibition protein.

3.3. IncL/M Plasmids: A Reservoir of β-Lactamase Genes

Among the 20 completely sequenced IncL/M plasmids, 18 encode at least one β-lactam resistance gene. In total, these plasmids carry 28 genes encoding 8 families of β-lactam hydrolyzing enzymes, representing all of the classes distinguished by Ambler: TEM, CTX-M, SHV, and KPC of Ambler class A; IMP and NDM of class B; FOX of class C; and OXA of class D [41, 42].

The most common is the gene (encoding the TEM-1 type enzyme), which is present in 9 plasmids: (i–iv) pFOX-7a, pKPN-068, pENT-e56, and pENT-d0d, representing clusters II and III in the phylogenetic tree (Figure 2), and (v–ix) pNDM-OM, pNDM-HK, pCTX-M3, pCTX-M360, and pEl1573, all belonging to cluster IV (Figure 2). Interestingly, all of the aforementioned plasmids also encode another β-lactamase inactivating a wider range of β-lactams. The presence of this second β-lactamase gene reflects the relatively narrow substrate specificity of the TEM-1 type enzyme, which is capable of hydrolyzing only penicillins and narrow-spectrum cephalosporins (such as cephalothin or cefazolin), but not more recently developed higher-generation cephalosporins with an oxyimino side chain (oxyimino-cephalosporins) [2]. Thus, the resistance conferred by the TEM-1 enzyme (probably the most common among enteric bacteria [43]) is in fact currently ineffective and has been “bolstered” by the acquisition of other genes encoding β-lactamases with a broader specificity in the course of IncL/M plasmid evolution.

The IncL/M plasmids also frequently encode β-lactam hydrolyzing enzymes of the SHV family, which gathers more than 160 β-lactamases [44], including the common enzymes SHV-5 and SHV-12 [45]. The genes are carried by three closely related plasmids, pARM26, pIGT15, and pACM1 (cluster I in the phylogenetic tree), while genes are present within plasmids pKPN-068, pENT-e56, and pENT-d0d of the subcluster IIIA (Figure 2).

The IncL/M plasmids also encode enzymes representing the CTX-M family of ESBLs. These enzymes are less closely related to TEM or SHV β-lactamases but show high similarity to the β-lactamases of various Kluyvera species [46]. Three of the IncL/M plasmids encode the CTX-M family β-lactamases: (i-ii) pCTX-M3 and pCTX-M360 () and (iii) pJEG011 () (Figure 2).

Another class of β-lactamases encoded by the IncL/M plasmids is represented by KPC-4, a carbapenemase of the KPC family. The gene encoding this enzyme is located within the transposon Tn4401f embedded in the plasmid pNE1280 [20].

Several IncL/M plasmids also encode metallo-β-lactamases (MBL) of Ambler class B, that is, enzymes that require metal ions as cofactors for their activity [47]. MBLs are the most clinically important carbapenemases due to their ability to hydrolyze almost all β-lactams, except monobactams. Moreover, they are not susceptible to therapeutic β-lactam inhibitors, for example, clavulanate [48]. MBL genes were found within (i) pEl1573 ( gene), (ii) pKOI-34 (), and (iii-iv) two nearly identical plasmids of the subcluster IVA, pNDM-HK and pNDM-OM () (Figure 2). It is important to note that the and genes of pEl1573 and pKOI-34 are in fact class 1 integron gene cassettes, which is typical for most, if not all, genes encoding IMP-, VIM-, and GIM-type MBLs [47].

An Ambler class C β-lactamase (AmpC-type, CBL) is encoded by only one IncL/M plasmid, pFOX-7a, which was isolated from strains of Klebsiella pneumoniae associated with an outbreak in a neonatal intensive care unit in central Italy [15]. The FOX-7 enzyme can hydrolyze extended-spectrum cephalosporins (e.g., cephamycins) and is resistant to various combinations of β-lactamase inhibitors [15]. The gene is unique in the current pan-genome of the IncL/M plasmids (Figure 2, Table 2).

Four of the IncL/M plasmids (pOXA-48, pJEG011, pKPoxa-48N1, and pE71T) (subcluster IIIB; Figure 2) carry the gene encoding a β-lactamase of Ambler class D. This enzyme is an OXA-family carbapenemase, which can hydrolyze penicillins and carbapenems but not extended-spectrum cephalosporins [21].

Epidemiological surveys have revealed that IncL/M plasmids play an important role in the global dissemination of β-lactam resistance genes (e.g., [49]). These replicons are not simply carriers of these resistance genes; they may also be considered “donors” of bla genes to other replicons coresiding in a particular host.

Close inspection of the IncL/M plasmid genomes revealed that the majority of their β-lactamase genes are associated with transposable elements (e.g., (i) is present within Tn2 of pCTX-M360, pCTX-M3, pNDM-HK, pNDM-OM, and pEl1573, (ii) was mobilized by ISEcp1 into pCTX-M3 and pCTX-M360, and (iii) occurs in Tn1999 of pOXA-48a) or they persist in the form of integron gene cassettes ( of pEl1573 and of pKOI-34). This localization significantly enhances the “mobility” of the resistance genes, which can be readily transferred from the IncL/M plasmids into bacterial chromosomes, as shown for the gene associated with the IS1R-based composite transposon Tn6237 [50]. However, an even greater epidemiological threat is posed by the transfer of bla genes into other plasmids coresiding in a bacterial cell. This may result in the generation of novel resistance plasmids with a host range that is different from that of the parental IncL/M plasmids. Therefore, plasmid-mediated gene transfer can play a fundamental role in the crossing of taxonomic boundaries and may significantly influence the prevalence of β-lactam resistance.

It is notable that 13 of the analyzed IncL/M plasmids also contain other AR genes, which confer resistance to antibiotics representing 8 drug classes: aminoglycosides, macrolides, quinolones, trimethoprim, sulfonamides, bleomycin, chloramphenicol, and tetracycline (Figure 2). Interestingly, this phenomenon of multiresistance has also been observed in several other types of plasmids encoding extended-spectrum β-lactamases (e.g., [51]). In consequence, the choice of appropriate antibiotics to eliminate β-lactamase-producing pathogenic bacterial strains is becoming more and more limited [52].

3.4. Biogeography of the IncL/M Plasmids

Although IncL/M broad host range, self-transferable plasmids play an important role in the horizontal transmission of multiresistance phenotypes among Enterobacteriaceae, still very little is known about the diversity and distribution of these replicons in different environments. As mentioned above, the genetic structure of only 20 replicons of this group has been revealed to date. However, database searches (performed at the NCBI website) produced some information about four other members of the IncL/M group that have been partially sequenced and subjected to molecular analyses. These are R446b of Morganella morganii [53], R471a of Serratia marcescens [54], pMU407.1 of Klebsiella pneumoniae [55], and p61/9 of Salmonella enterica serovar Typhimurium [56]. Moreover, in depth analysis of sequence accessions in the NCBI database yielded further information concerning IncL/M plasmids (usually identified by PCR-based replicon typing) in samples originating from various environments. Most of the detected IncL/M plasmids were carried by pathogenic strains of Enterobacteriaceae isolated from hospitalized patients. These strains originated from 27 countries: Albania [57], Algeria [58], Argentina [59], Australia [60], Belgium [61], Brazil [62], Bulgaria [63], Canada [64], China [65], Croatia [66], Denmark [67], Egypt [21], France [68], Greece [69], Kenya [70], Korea [71], Lebanon [21], Libya [72], Morocco [21], Philippines [69], Portugal [73], Russia [74], Spain [75], Switzerland [76], Tunisia [77], Turkey [21], and USA [78]. IncL/M plasmids were also found in enterobacteria isolated from companion animals in Italy [79] and from an urban wastewater treatment plant in Algeria [80]. Thus, IncL/M plasmids have so far been identified in 31 countries on 6 continents, which points to their global distribution (Figure 3). Notably, the majority of strains carrying the IncL/M plasmids were identified in countries located near the Mediterranean Sea and in Western Europe (Figure 3).

Figure 3: Geographical distribution of IncL/M plasmids.

Majority of the IncL/M plasmids were isolated from pathogenic strains of Enterobacteriaceae in the course of epidemiological studies. The unique genes found within these plasmids are usually involved in antibiotic resistance (Table 2) and may be linked with the specific medical treatment in the particular health care unit. This exemplifies the role of mobile genetic elements in transfer of genes, enabling bacteria to improve their fitness under local stress conditions [81]. Such phenomenon is common for environmental bacterial strains, which are able to survive under various harsh conditions (e.g., [82–84]). This study illustrates that the IncL/M plasmids are not exclusively associated with pathogenic enterobacteria but are also found in nonnosocomial environments, including communal wastes. Wide dissemination of these multiresistance plasmids and their possible transfer into pathogenic bacteria make them an important and considerable epidemiological threat.

4. Conclusions

The plasmids of the IncL/M incompatibility group are broad host range, multiresistance, self-transmissible replicons, which actively participate in the horizontal transfer of antibiotic resistance genes. These replicons have been associated with several outbreaks of disease caused by pathogenic strains of Enterobacteriaceae all over the world. They are also involved in the dissemination of β-lactam resistance, since they carry genes encoding enzymes representing all four Ambler classes of β-lactamases: Class A: TEM-1, SHV-5, SHV-12, CTX-M3, CTX-M14, and KPC-4; Class B: IMP-4, IMP-34, and NDM-1; Class C: FOX-7; and Class D: OXA-48.

Detailed analysis of the IncL/M plasmid genomes revealed that they have highly conserved backbones and share significant gene synteny. Moreover, phylogenetic analysis showed that these replicons may be grouped into four clusters, which also reflect the distribution of the antibiotic resistance determinants.

This study is the first to present available data indicating the global dissemination of bacteria carrying IncL/M plasmids. These multiresistance replicons not only are maintained by pathogenic strains of Enterobacteriaceae but also have been detected in bacteria inhabiting different nonnosocomial environments. A good example is the β-lactamase-encoding plasmid pARM26 characterized in this study, which was isolated from a wastewater treatment plant in Poland. Its identification strongly suggests that IncL/M plasmids have the ability to persist in various ecological niches even in the absence of direct antibiotic selection. Therefore, these plasmids constitute a rich reservoir of AR genes that may be disseminated among diverse bacteria (including pathogenic strains) in the natural environment.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This work was supported by the National Science Centre, Poland (Grant 2012/05/N/NZ9/01262) and the Ministry of Science and Higher Education, Poland (Grant DPN/N58/COST/2010).

References

K. Bush, “Bench-to-bedside review: the role of β-lactamases in antibiotic-resistant Gram-negative infections,” Critical Care, vol. 14, no. 3, article 224, 2010.

S. M. Drawz and R. A. Bonomo, “Three decades of β-lactamase inhibitors,” Clinical Microbiology Reviews, vol. 23, no. 1, pp. 160–201, 2010.

K. Bush, “The ABCD's of β-lactamase nomenclature,” Journal of Infection and Chemotherapy, vol. 19, no. 4, pp. 549–559, 2013.

L. Poirel, C. Héritier, I. Podglajen, W. Sougakoff, L. Gutmann, and P. Nordmann, “Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV β-lactamase that compromises the efficacy of imipenem,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 2, pp. 755–758, 2003.

A. Carattoli, “Plasmids and the spread of resistance,” International Journal of Medical Microbiology, vol. 303, no. 6-7, pp. 298–304, 2013.

C. M. Thomas and K. M. Nielsen, “Mechanisms of, and barriers to, horizontal gene transfer between bacteria,” Nature Reviews Microbiology, vol. 3, no. 9, pp. 711–721, 2005.

M. Shintani, Z. K. Sanchez, and K. Kimbara, “Genomics of microbial plasmids: classification and identification based on replication and transfer systems and host taxonomy,” Frontiers in Microbiology, vol. 6, article 242, 2015.

A. Carattoli, “Resistance plasmid families in Enterobacteriaceae,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 6, pp. 2227–2238, 2009.

A. Carattoli, S. N. Seiffert, S. Schwendener, V. Perreten, A. Endimiani, and P. J. Janssen, “Differentiation of IncL and IncM plasmids associated with the spread of clinically relevant antimicrobial resistance,” PLoS ONE, vol. 10, no. 5, Article ID e0123063, 2015.

K. E. Preston, S. A. Hitchcock, A. Y. Aziz, and J. A. Tine, “The complete nucleotide sequence of the multi-drug resistance-encoding IncL/M plasmid pACM1,” Plasmid, vol. 76, pp. 54–65, 2014.

M. Golebiewski, I. Kern-Zdanowicz, M. Zienkiewicz et al., “Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement in spread of the extended-spectrum β-lactamase gene ,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 11, pp. 3789–3795, 2007.

W.-H. Zhu, L. Luo, J.-Y. Wang et al., “Complete nucleotide sequence of pCTX-M360, an intermediate plasmid between pEL60 and pCTX-M3, from a multidrug-resistant Klebsiella pneumoniae strain isolated in China,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 12, pp. 5291–5293, 2009.

K. Power, J. Wang, M. Karczmarczyk et al., “Molecular analysis of OXA-48-carrying conjugative IncL/M-Like plasmids in clinical isolates of klebsiella pneumoniae in Ireland,” Microbial Drug Resistance, vol. 20, no. 4, pp. 270–274, 2014.

S. R. Partridge, A. N. Ginn, I. T. Paulsen, and J. R. Iredell, “pEl1573 carrying , from Sydney, Australia, is closely related to other IncL/M plasmids,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 11, pp. 6029–6032, 2012.

V. Di Pilato, F. Arena, T. Giani, V. Conte, S. Cresti, and G. M. Rossolini, “Characterization of pFOX-7a, a conjugative IncL/M plasmid encoding the FOX-7 AmpC-type β-lactamase, involved in a large outbreak in a neonatal intensive care unit,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 10, pp. 2620–2624, 2014.

B. A. Espedido, J. A. Steen, H. Ziochos et al., “Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution,” PLoS ONE, vol. 8, no. 3, Article ID e59920, 2013.

S. Berger, C. Alauzet, N. Aissa et al., “Characterization of a new -carrying plasmid in Enterobacteriaceae,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 8, pp. 4064–4067, 2013.

P. L. Ho, W. U. Lo, M. K. Yeung et al., “Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong,” PLoS ONE, vol. 6, no. 3, Article ID e17989, 2011.

R. A. Bonnin, P. Nordmann, A. Carattoli, and L. Poirel, “Comparative genomics of IncL/M-type plasmids: evolution by acquisition of resistance genes and insertion sequences,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 1, pp. 674–676, 2013.

K. A. Bryant, T. C. van Schooneveld, I. Thapa et al., “KPC-4 is encoded within a truncated Tn4401 in an IncL/M plasmid, pNE1280, isolated from Enterobacter cloacae and Serratia marcescens,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 1, pp. 37–41, 2013.

L. Poirel, R. A. Bonnin, and P. Nordmann, “Genetic features of the widespread plasmid coding for the carbapenemase OXA-48,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 1, pp. 559–562, 2011.

G. C. Foster, G. C. McGhee, A. L. Jones, and G. W. Sundin, “Nucleotide sequences, genetic organization, and distribution of pEU30 and pEL60 from Erwinia amylovora,” Applied and Environmental Microbiology, vol. 70, no. 12, pp. 7539–7544, 2004.

D. Hanahan, “Studies on transformation of Escherichia coli with plasmids,” Journal of Molecular Biology, vol. 166, no. 4, pp. 557–580, 1983.

P. Zaleski, R. Wolinowska, K. Strzezek, A. Lakomy, and A. Plucienniczak, “The complete sequence and segregational stability analysis of a new cryptic plasmid pIGWZ12 from a clinical strain of Escherichia coli,” Plasmid, vol. 56, no. 3, pp. 228–232, 2006.

J. Sambrook and D. W. Russell, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, NY, USA, 2001.

S. Conlan, P. J. Thomas, C. Deming et al., “Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae,” Science Translational Medicine, vol. 6, no. 254, Article ID 254ra126, 2014.

N. Shigemoto, S. Kayama, R. Kuwahara et al., “A novel metallo-β-lactamase, IMP-34, in Klebsiella isolates with decreased resistance to imipenem,” Diagnostic Microbiology and Infectious Disease, vol. 76, no. 1, pp. 119–121, 2013.

S. R. Kushner, “An improved method for transformation of E. coli with ColE1 derived plasmids,” in Genetic Engineering, H. B. Boyer and S. Nicosia, Eds., pp. 17–23, Elsevier, North-Holland, Amsterdam, The Netherlands, 1978.

T. Carver, M. Berriman, A. Tivey et al., “Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database,” Bioinformatics, vol. 24, no. 23, pp. 2672–2676, 2008.

S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997.

P. Siguier, J. Perochon, L. Lestrade, J. Mahillon, and M. Chandler, “ISfinder: the reference centre for bacterial insertion sequences,” Nucleic Acids Research, vol. 34, pp. D32–D36, 2006.

M. J. Sullivan, N. K. Petty, and S. A. Beatson, “Easyfig: a genome comparison visualizer,” Bioinformatics, vol. 27, no. 7, Article ID btr039, pp. 1009–1010, 2011.

J. Blom, S. P. Albaum, D. Doppmeier et al., “EDGAR: a software framework for the comparative analysis of prokaryotic genomes,” BMC Bioinformatics, vol. 10, article 154, 2009.

R. C. Edgar, “MUSCLE: multiple sequence alignment with high accuracy and high throughput,” Nucleic Acids Research, vol. 32, no. 5, pp. 1792–1797, 2004.

G. Talavera and J. Castresana, “Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments,” Systematic Biology, vol. 56, no. 4, pp. 564–577, 2007.

J. Felsenstein, “PHYLIP—phylogeny inference package (Version 3.2),” Cladistics, vol. 5, pp. 164–166, 1989.

R. D. Page, “TreeView: an application to display phylogenetic trees on personal computers,” Computer Applications in the Biosciences, vol. 12, no. 4, pp. 357–358, 1996.

D. J. LeBlanc and R. P. Mortlock, “Metabolism of D-arabinose: a new pathway in Escherichia coli,” Journal of Bacteriology, vol. 106, no. 1, pp. 90–96, 1971.

M. Ashiuchi and H. Misono, “Biochemical evidence that Escherichia coli hyi (orf b0508, gip) gene encodes hydroxypyruvate isomerase,” Biochimica et Biophysica Acta, vol. 1435, no. 1-2, pp. 153–159, 1999.

K. E. Preston, M. A. Kacica, R. J. Limberger, W. A. Archinal, and R. A. Venezia, “The resistance and integrase genes of pACM1, a conjugative multiple-resistance plasmid, from Klebsiella oxytoca,” Plasmid, vol. 37, no. 2, pp. 105–118, 1997.

R. P. Ambler, “The structure of beta-lactamases,” Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, vol. 289, no. 1036, pp. 321–331, 1980.

B. G. Hall and M. Barlow, “Revised Ambler classification of β-lactamases,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 6, pp. 1050–1051, 2005.

R. Cooksey, J. Swenson, N. Clark, E. Gay, and C. Thornsberry, “Patterns and mechanisms of β-lactam resistance among isolates of Escherichia coli from hospitals in the United States,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 5, pp. 739–745, 1990.

K. Bush, “Proliferation and significance of clinically relevant beta-lactamases,” Annals of the New York Academy of Sciences, vol. 1277, no. 1, pp. 84–90, 2013.

D. L. Paterson, K. M. Hujer, A. M. Hujer et al., “Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 11, pp. 3554–3560, 2003.

J. W. Decousser, L. Poirel, and P. Nordmann, “Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 12, pp. 3595–3598, 2001.

T. R. Walsh, M. A. Toleman, L. Poirel, and P. Nordmann, “Metallo-β-lactamases: the quiet before the storm?” Clinical Microbiology Reviews, vol. 18, no. 2, pp. 306–325, 2005.

J. Li, Z. Hu, and Q. Hu, “Isolation of the first IMP-4 metallo-β-lactamase producing Klebsiella Pneumoniae in Tianjin, China,” Brazilian Journal of Microbiology, vol. 43, no. 3, pp. 917–922, 2012.

A. Potron, L. Poirel, E. Rondinaud, and P. Nordmann, “Intercontinental spread of OXA-48 β-lactamase-producing enterobacteriaceae over a 11-year period, 2001 to 2011,” Eurosurveillance, vol. 18, no. 31, Article ID 20549, 2013.

R. Beyrouthy, F. Robin, J. Delmas et al., “IS1R-mediated plasticity of IncL/M plasmids leads to the insertion of bla OXA-48 into the Escherichia coli chromosome,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 7, pp. 3785–3790, 2014.

T. O. Rahube, L. S. Viana, G. Koraimann, and C. K. Yost, “Characterization and comparative analysis of antibiotic resistance plasmids isolated from a wastewater treatment plant,” Frontiers in Microbiology, vol. 5, article 558, 2014.

D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005.

R. W. Hedges, N. Datta, J. N. Coetzee, and S. Dennison, “R factors from Proteus morganii,” Journal of General Microbiology, vol. 77, no. 2, pp. 249–259, 1973.

C. Ho, O. I. Kulaeva, A. S. Levine, and R. Woodgate, “A rapid method for cloning mutagenic DNA repair genes: isolation of umu—complementing genes from multidrug resistance plasmids R391, R446b, and R471a,” Journal of Bacteriology, vol. 175, no. 17, pp. 5411–5419, 1993.

V. Athanasopoulos, J. Praszkier, and A. J. Pittard, “The replication of an IncL/M plasmid is subject to antisense control,” Journal of Bacteriology, vol. 177, no. 16, pp. 4730–4741, 1995.

A. M. Dionisi, C. Lucarelli, S. Owczarek, I. Luzzi, and L. Villa, “Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar typhimurium,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 9, pp. 4019–4021, 2009.

F. Tosini, P. Visca, I. Luzzi et al., “Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 12, pp. 3053–3058, 1998.

T. Naas, C. Bentchouala, G. Cuzon et al., “Outbreak of Salmonella enterica serotype infantis producing ArmA 16S RNA methylase and CTX-M-15 extended-spectrum β-lactamase in a neonatology ward in Constantine, Algeria,” International Journal of Antimicrobial Agents, vol. 38, no. 2, pp. 135–139, 2011.

S. A. Gomez, F. G. Pasteran, D. Faccone et al., “Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina,” Clinical Microbiology and Infection, vol. 17, no. 10, pp. 1520–1524, 2011.

S. R. Partridge, L. C. Thomas, A. N. Ginn, A. M. Wiklendt, P. Kyme, and J. R. Iredell, “A novel gene cassette, aacA43, in a plasmid-borne class 1 integron,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2979–2982, 2011.

P. Bogaerts, M. Galimand, C. Bauraing et al., “Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 3, pp. 459–464, 2007.

L. N. Andrade, T. Curiao, J. C. Ferreira et al., “Dissemination of by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 7, pp. 3579–3583, 2011.

R. Markovska, I. Schneider, D. Ivanova, I. Mitov, and A. Bauernfeind, “Predominance of IncL/M and IncF plasmid types among CTX-M-ESBL-producing Escherichia coli and Klebsiella pneumoniae in Bulgarian hospitals,” APMIS, vol. 122, no. 7, pp. 608–615, 2014.

G. Peirano, J. Ahmed-Bentley, J. Fuller, J. E. Rubin, and J. D. D. Pitout, “Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years,” Journal of Clinical Microbiology, vol. 52, no. 5, pp. 1575–1581, 2014.

Y. Liu, L.-G. Wan, Q. Deng, X.-W. Cao, Y. Yu, and Q.-F. Xu, “First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital,” Epidemiology and Infection, vol. 143, no. 2, pp. 376–384, 2014.

E. Literacka, B. Bedenic, A. Baraniak et al., “ genes in Escherichia coli strains from Croatian hospitals are located in new () and widely spread ( and ) genetic structures,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1630–1635, 2009.

E. Bielak, R. D. Bergenholtz, M. S. Jørgensen, S. J. Sørensen, L. H. Hansen, and H. Hasman, “Investigation of diversity of plasmids carrying the bla TEM-52 gene,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 11, Article ID dkr331, pp. 2465–2474, 2011.

F. Compain, D. Decré, J.-P. Fulgencio, S. Berraho, G. Arlet, and C. Verdet, “Molecular characterization of DHA-1-producing Klebsiella pneumoniae isolates collected during a 4-year period in an intensive care unit,” Diagnostic Microbiology and Infectious Disease, vol. 80, no. 2, pp. 159–161, 2014.

G. Peirano, C. Lascols, M. Hackel, D. J. Hoban, and J. D. D. Pitout, “Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program,” Diagnostic Microbiology and Infectious Disease, vol. 78, no. 3, pp. 277–281, 2014.

J. Kiiru, P. Butaye, B. M. Goddeeris, and S. Kariuki, “Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992–2011),” BMC Microbiology, vol. 13, no. 1, article 109, 2013.

Y. J. Park, S. Y. Kim, J. K. Yu et al., “Spread of Serratia marcescens coharboring aac(6′)-Ib-cr, , armA, and carried by conjugative IncL/M type plasmid in Korean hospitals,” Microbial Drug Resistance, vol. 15, no. 2, pp. 97–102, 2009.

E. Lafeuille, D. Decré, F. Mahjoub-Messai, P. Bidet, G. Arlet, and E. Bingen, “OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients,” Microbial Drug Resistance, vol. 19, no. 6, pp. 491–497, 2013.

C. Rodrigues, E. Machado, H. Ramos, L. Peixe, and Â. Novais, “Expansion of ESBL-producing Klebsiella pneumoniae in hospitalized patients: a successful story of international clones (ST15, ST147, ST336) and epidemic plasmids (IncR, IncFIIK),” International Journal of Medical Microbiology, vol. 304, no. 8, pp. 1100–1108, 2014.

N. K. Fursova, S. D. Pryamchuk, I. V. Abaev et al., “Genetic environments of bla(CTX-M) genes located on conjugative plasmids of enterobacteriaceae nosocomial isolates collected in Russia within 2003–2007,” Antibiotiki i Khimioterapiya, vol. 55, no. 11-12, pp. 3–10, 2010.

J. Fernańdez, I. Montero, A. Fleites, and M. R. Rodicio, “Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012,” Journal of Clinical Microbiology, vol. 52, no. 9, pp. 3414–3417, 2014.

S. N. Seiffert, V. Perreten, S. Johannes, S. Droz, T. Bodmer, and A. Endimiani, “OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 4, pp. 2446–2449, 2014.

D. Elhani, L. Bakir, M. Aouni et al., “Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999–2005,” Clinical Microbiology and Infection, vol. 16, no. 2, pp. 157–164, 2010.

V. Bortolaia, K. H. Hansen, C. A. Nielsen, T. R. Fritsche, and L. Guardabassi, “High diversity of plasmids harbouring blaCMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 6, pp. 1492–1496, 2014.

V. Donati, F. Feltrin, R. S. Hendriksen et al., “Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in Klebsiella spp. from companion animals in Italy,” PLoS ONE, vol. 9, no. 3, Article ID e90564, 2014.

S. Alouache, V. Estepa, Y. Messai, E. Ruiz, C. Torres, and R. Bakour, “Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria,” Microbial Drug Resistance, vol. 20, no. 1, pp. 30–38, 2014.

X. Bellanger, H. Guilloteau, B. Breuil, and C. Merlin, “Natural microbial communities supporting the transfer of the IncP-1β plasmid pB10 exhibit a higher initial content of plasmids from the same incompatibility group,” Frontiers in Microbiology, vol. 5, article 637, 2014.

L. Dziewit and D. Bartosik, “Plasmids of psychrophilic and psychrotolerant bacteria and their role in adaptation to cold environments,” Frontiers in Microbiology, vol. 5, article 596, 2014.

L. Dziewit, A. Pyzik, M. Szuplewska et al., “Diversity and role of plasmids in adaptation of bacteria inhabiting the Lubin copper mine in Poland, an environment rich in heavy metals,” Frontiers in Microbiology, vol. 6, article 152, 2015.

M. G. López-Guerrero, E. Ormeño-Orrillo, J. L. Acosta et al., “Rhizobial extrachromosomal replicon variability, stability and expression in natural niches,” Plasmid, vol. 68, no. 3, pp. 149–158, 2012.